Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. May 25, 2018. Pamela Goldberg.

Executive Summary

The Medical Device Innovation Consortium has formed a strong bond with US FDA over its joint Case for Quality initiative. See what new MDIC CEO Pamela Goldberg said about the group's ongoing search for quality here.

"There’s always more to be done in the search for quality. Of course, that’s part of the watchword of MDIC, is getting the best quality medical devices to patients with the greatest effectiveness and efficiency. But in terms of quality, we have done a number of studies. We’ve done a number of reports, and are continuing to explore where we go down that path. We’ve worked on quality metrics for devices in key settings and in key verticals, and are continuing to look at where else we should be looking and where else we should be pushing initiatives to explore quality metrics. –Pamela Goldberg, CEO, Medical Device Innovation Consortium

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122725

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel